[FG] Khanna Gremmelmaier Nina

Ragozzino, S. et al. (2025) ‘MicroRNA whole-blood profiling in hospitalized patients with candidemia identified miR-125a-5p and miR-99b-5p as potential biomarkers for Candida albicans bloodstream infection’, 161. Available at: https://doi.org/10.1016/j.ijid.2025.108148.

Marchetti, Camille et al. (2025) ‘Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies: A Case–Control Study’, Mycoses, 68(10). Available at: https://doi.org/10.1111/myc.70123.

Selim Bouaouina et al. (2025) ‘Epistasis between drug resistance-conferring mutations in Mycobacterium tuberculosis’. Available at: https://doi.org/10.1101/2025.08.07.669101.

ElAbd, Hesham et al. (2025) ‘T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis’, Nature Medicine, 31(7), pp. 2306–2316. Available at: https://doi.org/10.1038/s41591-025-03692-w.

Kinoshita, Hannah et al. (2025) ‘T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy’, Transplantation and Cellular Therapy, 31(5), pp. 327–338. Available at: https://doi.org/10.1016/j.jtct.2025.02.019.

Frank, F.A. et al. (2025) ‘Current Concepts in Shoulder Periprosthetic Joint Infections—Are Shoulders the Same as Hips and Knees?’, Journal of Clinical Medicine, 14(8), p. 2578. Available at: https://doi.org/10.3390/jcm14082578.

van Delden, C. et al. (2025) ‘The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research’, Transplant Infectious Disease, 27(2). Available at: https://doi.org/10.1111/tid.70023.

Erdmann, Joana et al. (2025) ‘Amoxicillin Concentrations in Samples of Musculoskeletal Infections’, Helvetica Chimica Acta, 108(2). Available at: https://doi.org/10.1002/hlca.202400178.

Nyffeler, Ramon et al. (2025) ‘Fracture-related infections of the lower extremity – Analysis of costs and their drivers’, Injury. 28.12.2024, 56(2). Available at: https://doi.org/10.1016/j.injury.2024.112138.

Morin, Benedict (2025) Human musculoskeletal Staphylococcus aureus infections – characteristics of host-pathogen interactions and treatment failures. Doctoral Thesis. University of Basel.

Kusejko, Katharina et al. (2024) ‘Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study’, BMC Infectious Diseases, 24(1). Available at: https://doi.org/10.1186/s12879-024-10026-7.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-023-44157-3.

Bertagnolio, Silvia et al. (2024) ‘WHO global research priorities for antimicrobial resistance in human health’, The Lancet Microbe, 5(11). Available at: https://doi.org/10.1016/s2666-5247(24)00134-4.

Bausch, Severin et al. (2024) ‘Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study’, Antibiotics, 13(10), p. 928. Available at: https://doi.org/10.3390/antibiotics13100928.

Rentsch, Katharina M. et al. (2024) ‘Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations’, Antibiotics, 13(10), p. 970. Available at: https://doi.org/10.3390/antibiotics13100970.

Vock, Isabelle et al. (2024) ‘Quantifying aminoglycoside resistance in extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales clinical isolates: a retrospective cohort study’, Swiss Medical Weekly, 154(10). Available at: https://doi.org/10.57187/s.3904.

Goede, Jeroen S. et al. (2024) ‘Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies’, Swiss Medical Weekly, 154(9). Available at: https://doi.org/10.57187/s.3559.

Palianina, D. et al. (2024) ‘Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo’, Science advances, 10(34). Available at: https://doi.org/10.1126/sciadv.ado2048.

Hofer, Kevin D. et al. (2024) ‘B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma’, British Journal of Haematology, 205(2), pp. 722–725. Available at: https://doi.org/10.1111/bjh.19571.

Neofytos, D. and Khanna, N. (2024) ‘How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients’, Transplant Infectious Disease, 26(4). Available at: https://doi.org/10.1111/tid.14332.

Müller-Durovic, Bojana et al. (2024) ‘A metabolic dependency of EBV can be targeted to hinder B cell transformation’, Science (New York, N.Y.), 385(6704), p. eadk4898. Available at: https://doi.org/10.1126/science.adk4898.

De Greef, Julien et al. (2024) ‘Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Journal of Infection, 88(6). Available at: https://doi.org/10.1016/j.jinf.2024.106162.

Jantarug, Krittapas et al. (2024) ‘A Far-Red Fluorescent Probe to Visualize Gram-Positive Bacteria in Patient Samples’, ACS Infectious Diseases, 10(5), pp. 1545–1551. Available at: https://doi.org/10.1021/acsinfecdis.4c00060.

Couchepin, Jade et al. (2024) ‘Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae223.

Portillo, V. et al. (2024) ‘Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae201.

Salmanton-García, Jon et al. (2024) ‘Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022’, eClinicalMedicine, 71. Available at: https://doi.org/10.1016/j.eclinm.2024.102553.

Hosseini-Moghaddam, Seyed M. et al. (2024) ‘Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020’, American Journal of Transplantation, 24(4), pp. 653–668. Available at: https://doi.org/10.1016/j.ajt.2023.11.003.

Ragozzino, Silvio et al. (2024) ‘Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study’, Bone Marrow Transplantation, 59(2), pp. 278–281. Available at: https://doi.org/10.1038/s41409-023-02157-3.

Søgaard, Kirstine K. et al. (2024) ‘Evaluation of the clinical relevance of the Biofire© FilmArray pneumonia panel among hospitalized patients’, Infection, 52(1), pp. 173–181. Available at: https://doi.org/10.1007/s15010-023-02080-1.

Forrer, Pascal et al. (2024) ‘Unveiling signaling pathways inducing MHC class II expression in neutrophils’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1444558.

Hentzien, M. et al. (2024) ‘External validation of the Dat’AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older’, HIV Medicine, 25(1), pp. 72–82. Available at: https://doi.org/10.1111/hiv.13534.

Marais, Leonard C. et al. (2024) ‘Key aspects of soft tissue management in fracture-related infection: recommendations from an international expert group’, Archives of Orthopaedic and Trauma Surgery, 144(1), pp. 259–268. Available at: https://doi.org/10.1007/s00402-023-05073-9.

Sollier, Julie et al. (2024) ‘Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions’, Nature Microbiology, 9(1), pp. 1–3. Available at: https://doi.org/10.1038/s41564-023-01566-w.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23(1). Available at: https://doi.org/10.1186/s12879-023-08732-9.

Ehrenzeller S et al. (2023) ‘A qualitative study on the perception of infection prevention and control measures among healthcare workers without patient contact during the SARS-CoV-2 pandemic’, Antimicrobial Resistance and Infection Control, 12(1), p. 43. Available at: https://doi.org/10.1186/s13756-023-01246-8.

Arendrup, M.C. et al. (2023) ‘European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study’, Journal of Infection, 87(5), pp. 428–437. Available at: https://doi.org/10.1016/j.jinf.2023.08.001.

Palianina, D. et al. (2023) ‘A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications’, Molecular Therapy Methods and Clinical Development, 30, pp. 147–160. Available at: https://doi.org/10.1016/j.omtm.2023.06.007.

Baur, Katharina et al. (2023) ‘CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas’, Bone Marrow Transplantation, 58(9), pp. 1048–1050. Available at: https://doi.org/10.1038/s41409-023-02016-1.

Baur, Katharina et al. (2023) ‘CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas’, Bone Marrow Transplantation, 58(9), pp. 1048–1050. Available at: https://doi.org/10.1038/s41409-023-02016-1.

Lindsay, Julian et al. (2023) ‘Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms’, Blood Advances, 7(13), pp. 3140–3145. Available at: https://doi.org/10.1182/bloodadvances.2022009562.

Hoenigl M et al. (2023) ‘Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study’, The Lancet Infectious Diseases, 23(6), pp. 751–761. Available at: https://doi.org/10.1016/s1473-3099(22)00872-6.

Neofytos D et al. (2023) ‘Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update’, Open Forum Infectious Diseases, 10(6), p. ofad247. Available at: https://doi.org/10.1093/ofid/ofad247.

Palianina, D. et al. (2023) Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist<i>in vivo</i>. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.05.30.542809.

Capoferri, Gioele et al. (2023) ‘Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation’, Bone Marrow Transplantation, 58(5), pp. 597–599. Available at: https://doi.org/10.1038/s41409-023-01936-2.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6(4), p. E2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6(4), p. e2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Bettonte S et al. (2023) ‘Management of Drug-Drug Interactions between Long-Acting Cabotegravir and Rilpivirine and Comedications with Inducing Properties: A Modeling Study’, Clinical Infectious Diseases, 76(7), pp. 1225–1236. Available at: https://doi.org/10.1093/cid/ciac901.

Escrihuela-Vidal F et al. (2023) ‘Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort’, Clinical Microbiology and Infection, 29(4), pp. 498–505. Available at: https://doi.org/10.1016/j.cmi.2022.10.019.

Nguyen, A. et al. (2023) ‘Hot Topics 2022: die Sicht von jungen Infektiologinnen und Infektiologen’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2023.09312.

Labarile, Marco et al. (2023) ‘Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach’, Journal of Infectious Diseases, 227(4), pp. 554–564. Available at: https://doi.org/10.1093/infdis/jiac457.

Berton M et al. (2023) ‘Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals’, Clinical Pharmacokinetics, 62(2), pp. 277–295. Available at: https://doi.org/10.1007/s40262-022-01194-3.

Schaeffer Thibault et al. (2023) ‘Long-Term Follow-Up after Mycobacterium Chimaera Infection Following Cardiac Surgery: Single-Center Experience’, Journal of Clinical Medicine, 12(3). Available at: https://doi.org/10.3390/jcm12030948.

Busca A et al. (2023) ‘Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry’, Frontiers in Immunology, 14, p. 1125030. Available at: https://doi.org/10.3389/fimmu.2023.1125030.

Criscuolo M et al. (2023) ‘SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report’, Journal of Investigational Allergology and Clinical Immunology, 33(3), pp. 225–227. Available at: https://doi.org/10.18176/jiaci.0845.

Marchesi F et al. (2023) ‘COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)’, Haematologica, 108(1), pp. 22–33. Available at: https://doi.org/10.3324/haematol.2022.280847.

Ndege, R. et al. (2023) ‘Ultrasononography in managing extrapulmonary tuberculosis: a randomized, controlled, parallel, superiority, open-label trial’, Clin Infect Dis, 76(6), pp. 1013–1021. Available at: https://doi.org/10.1093/cid/ciac871.

Sava M et al. (2023) ‘Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates’, Bone Marrow Transplantation. Springer Nature, 58(1). Available at: https://doi.org/10.1038/s41409-022-01851-y.

von Rotz, M. et al. (2023) ‘A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center’, Antimicrob Resist Infect Control, 12(1), p. 38. Available at: https://doi.org/10.1186/s13756-023-01242-y.

Walti, Carla Simone et al. (2023) ‘New Treatment Options for Refractory/Resistant CMV Infection’, Transplant International, 36. Available at: https://doi.org/10.3389/ti.2023.11785.

Chammartin F et al. (2022) ‘CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study’, Journal of Acquired Immune Deficiency Syndromes, 91(5), pp. 508–515. Available at: https://doi.org/10.1097/qai.0000000000003094.

Castellanos-Rueda R et al. (2022) ‘speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing’, Nature Communications, 13(1), p. 6555. Available at: https://doi.org/10.1038/s41467-022-34141-8.

Ehrenzeller S et al. (2022) ‘A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic’, Antimicrobial Resistance and Infection Control, 11(1), p. 30. Available at: https://doi.org/10.1186/s13756-022-01068-0.

Pham, Truong-Thanh et al. (2022) ‘Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients’, American Journal of Transplantation, 22(12), pp. 3031–3046. Available at: https://doi.org/10.1111/ajt.17184.

Sgaard, K.K. et al. (2022) ‘Helicobacter cinaedi als seltener Auslöser bei einem immunkompetenten Patienten’, Swiss Medical Forum ‒ Schweizerisches Medizin-Forum [Preprint]. Available at: https://doi.org/10.4414/smf.2022.09011.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic’, Journal of Hospital Infection. W.B. Saunders Ltd, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Palianina, D. et al. (2022) A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.514542.

Weisser, Maja et al. (2022) ‘Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients’, Transfusion, 62(10), pp. 1997–2011. Available at: https://doi.org/10.1111/trf.17083.

Blaskovich Mark A.T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj238.

Blaskovich, Mark A. T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj2381.

Blaskovich MAT et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662), p. eabj2381. Available at: https://doi.org/10.1126/scitranslmed.abj238.

Berton M et al. (2022) ‘Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models’, Clinical Pharmacokinetics, 61(9), pp. 1251–1270. Available at: https://doi.org/10.1007/s40262-022-01132-3.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial’, The Lancet Respiratory Medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/s2213-2600(22)00086-8.

Thoueille P et al. (2022) ‘Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland’, Pharmaceutics, 14(8). Available at: https://doi.org/10.3390/pharmaceutics14081588.

Walti, Carla S. et al. (2022) ‘Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients’, Current Opinion in Infectious Diseases, 35(4), pp. 302–311. Available at: https://doi.org/10.1097/qco.0000000000000838.

Weisser, M. et al. (2022) Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1828291/v1.

Callegari, Ilaria et al. (2022) ‘Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch’, EMBO Reports, 23(7). Available at: https://doi.org/10.15252/embr.202153956.

Averbuch D et al. (2022) ‘Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Clinical Infectious Diseases, 75(1), pp. 88–97. Available at: https://doi.org/10.1093/cid/ciab866.

van den Bogaart L et al. (2022) ‘Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study’, Journal of Infection, 85(1), pp. 1–7. Available at: https://doi.org/10.1016/j.jinf.2022.05.019.

Nguyen H et al. (2022) ‘Correction: Identifying and characterizing trans women in the swiss HIV cohort study as an epidemiologically distinct risk group (Clinical Infectious Diseases DOI: 10.1093/cid/ciab628)’, Clinical Infectious Diseases. Oxford University Press, 74(12). Available at: https://doi.org/10.1093/cid/ciac242.

Tepekule Burcu et al. (2022) ‘Impact of Latent Tuberculosis on Diabetes’, Journal of Infectious Diseases, 225(12), pp. 2229–2234. Available at: https://doi.org/10.1093/infdis/jiac054.

Balakrishna, Suraj et al. (2022) ‘Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study’, Journal of Infectious Diseases, 225(9), pp. 1592–1600. Available at: https://doi.org/10.1093/infdis/jiab573.

Peter, Jelissa Katharina et al. (2022) ‘SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination’, Microorganisms, 10(5). Available at: https://doi.org/10.3390/microorganisms10050857.

Nguyen H et al. (2022) ‘Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group’, Clinical Infectious Diseases, 74(8), pp. 1468–1475. Available at: https://doi.org/10.1093/cid/ciab628.

Busca A et al. (2022) ‘COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP’, Blood Advances, 6(7), pp. 2427–2433. Available at: https://doi.org/10.1182/bloodadvances.2021005616.

Cardoso E et al. (2022) ‘Is sleep disordered breathing a risk factor for COVID-19 or vice versa?’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00034-2022.

Salina, Anna et al. (2022) ‘Multiplex bacterial PCR in the bronchoalveolar lavage fluid of non-intubated patients with suspected pulmonary infection: a quasi-experimental study’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00595-2021.

Stader F et al. (2022) ‘Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients’, Clinical Pharmacology and Therapeutics, 111(3), pp. 579–584. Available at: https://doi.org/10.1002/cpt.2402.

Jakeman B et al. (2022) ‘Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: A prospective cohort study’, Journal of Antimicrobial Chemotherapy, 77(2), pp. 492–499. Available at: https://doi.org/10.1093/jac/dkab386.

Ragozzino S et al. (2022) ‘Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples from Swiss Tertiary Care Hospitals’, Open Forum Infectious Diseases, 9(2), p. ofab638. Available at: https://doi.org/10.1093/ofid/ofab638.

Scherrer AU et al. (2022) ‘Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)’, International Journal of Epidemiology, 51(1), pp. 33–34J. Available at: https://doi.org/10.1093/ije/dyab141.

Bock, Lukas et al. (2022) ‘Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae’, Environmental Research, 215(Pt 2), p. 114146. Available at: https://doi.org/10.1016/j.envres.2022.114146.

Bruningk, Sarah C. et al. (2022) ‘Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area’, Virus Evolution, 8(1), p. veac002. Available at: https://doi.org/10.1093/ve/veac002.

Carere-Sigl, Anja et al. (2022) ‘FimH antagonists prevent biofilm formation on catheter surfaces’, Carbohydrate Chemistry, 45, pp. 519–536. Available at: https://doi.org/10.1039/9781839164538-00519.

Jahn K et al. (2022) ‘Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning’, European Respiratory Journal. European Respiratory Society, 59(1). Available at: https://doi.org/10.1183/13993003.01136-2021.

Kampouri, Eleftheria et al. (2022) ‘Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians’, Expert Review of Hematology, 15(4), pp. 305–320. Available at: https://doi.org/10.1080/17474086.2022.2063833.

Kusejko, K. et al. (2022) ‘Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics’, J Acquir Immune Defic Syndr, 90(4), pp. e4–e12. Available at: https://doi.org/10.1097/qai.0000000000002949.

Kvarda, Peter et al. (2022) ‘Perioperative myocardial injury and mortality after revision surgery for orthopaedic device-related infection’, The Bone & Joint Journal, 104-B(6), pp. 696–702. Available at: https://doi.org/10.1302/0301-620x.104b6.bjj-2021-1486.r1.

Magnolini, R. et al. (2022) ‘Stigma-directed services (Stig2Health) to improve “linkage to care” for people living with HIV in rural Tanzania: study protocol for a nested pre-post implementation study within the Kilombero and Ulanga Antiretroviral Cohort’, AAS Open Res, 5, p. 14. Available at: https://doi.org/10.12688/aasopenres.13353.2.

Ndege, R. C. et al. (2022) ‘Failure to return pillbox is a predictor of being lost to follow-up among people living with HIV on antiretroviral therapy in rural Tanzania’, HIV Med, 23(6), pp. 661–672. Available at: https://doi.org/10.1111/hiv.13223.

Palianina, D. (2022) Improving EBV-specific T cell therapy: lineage tracing and EBV stem cell memory T cells . Doctoral Thesis.